Imagen de Portada

Utilising high-dimensional data in randomised clinical trials: a review of methods and practice

Fuente: arXiv

Guardado en:

Detalles Bibliográficos
Autores principales:	Cherlin, Svetlana, Bigirumurame, Theophile, Grayling, Michael J, Nsengimana, Jérémie, Ouma, Luke, Santaolalla, Aida, Wan, Fang, Williamson, S Faye, Wason, James M S
Formato:	Preprint
Publicado:	2023
Materias:	Applications
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Evaluating the impact of outcome delay on the efficiency of two-arm group-sequential trials
por: Mukherjee, Aritra, et al.
Publicado: (2023)

Developing a predictive signature for two trial endpoints using the cross-validated risk scores method
por: Cherlin, Svetlana, et al.
Publicado: (2020)

Evaluating the impact of outcome delay on the efficiency of sample size re-estimation
por: Mukherjee, Aritra, et al.
Publicado: (2026)

Cross-validated risk scores adaptive enrichment (CADEN) design
por: Cherlin, Svetlana, et al.
Publicado: (2021)

Augmented Binary Method for Basket Trials (ABBA)
por: Cherlin, Svetlana, et al.
Publicado: (2024)

Optimal Bayesian stepped-wedge cluster randomised trial designs for binary outcome data
por: Etfer, Laura, et al.
Publicado: (2024)

Confidence intervals for adaptive trial designs II: Case study and practical guidance
por: Robertson, David S., et al.
Publicado: (2024)

Confidence intervals for adaptive trial designs I: A methodological review
por: Robertson, David S., et al.
Publicado: (2024)

A systematic review of sample size determination in Bayesian randomized clinical trials: full Bayesian methods are rarely used
por: Marks, Yanara, et al.
Publicado: (2025)

Evaluation of clinical utility in emulated clinical trials
por: Hruza, Johannes, et al.
Publicado: (2025)

Data-driven controlled subgroup selection in clinical trials
por: Müller, Manuel M., et al.
Publicado: (2025)

Equipoise calibration of clinical trial design
por: Rigat, Fabio
Publicado: (2025)

Comparing Methods of Expert Elicitation for Treatment Effect or Borrowing Parameters in Standard and Rare Disease Clinical Trials: A Systematic Mapping Study
por: Morgan, Laura M., et al.
Publicado: (2025)

Visualisation of multi-indication randomised control trial evidence to support decision-making in oncology: a case study on bevacizumab
por: Anwer, Sumayya, et al.
Publicado: (2025)

Incorporating estimands into meta-analyses of clinical trials
por: Remiro-Azócar, Antonio, et al.
Publicado: (2025)

Bayesian sample size determination using robust commensurate priors with interpretable discrepancy weights
por: Whitehead, Lou E., et al.
Publicado: (2024)

Benchmarking covariate-adjustment strategies for randomized clinical trials
por: Shao, Yulin, et al.
Publicado: (2026)

The R.O.A.D. to clinical trial emulation
por: Bertsimas, Dimitris, et al.
Publicado: (2024)

Methods for non-proportional hazards in clinical trials: A systematic review
por: Bardo, Maximilian, et al.
Publicado: (2023)

A novel Phase I clinical trial design with unequal cohort sizes
por: Zhu, Xiaojun
Publicado: (2024)

A cautious use of auxiliary outcomes for decision-making in randomized clinical trials
por: Russo, Massimiliano, et al.
Publicado: (2025)

Hybrid methods for missing categorical covariates in Cox model
por: Dioni, Abdoulaye, et al.
Publicado: (2025)

Differences in Performance of Bayesian Dynamic Borrowing and Synthetic Control Methods: A Case Study of Pediatric Atopic Dermatitis
por: Cizauskas, Nicole, et al.
Publicado: (2026)

Can artificial intelligence predict clinical trial outcomes?
por: Jin, Shuyi, et al.
Publicado: (2024)

Bias reduction in g-computation for covariate adjustment in randomized clinical trials
por: Zhang, Xin, et al.
Publicado: (2025)

Causal language jumps in clinical practice guidelines for diabetes management
por: Wang, Keling, et al.
Publicado: (2025)

The efficiencies of pilot feasibility trials in rare diseases using Bayesian methods
por: Maleyeff, Lara, et al.
Publicado: (2025)

Synergy Area with FDR-controlled Evaluation (SAFE) to robustly assess safety profile in clinical trials
por: Zhan, Tianyu, et al.
Publicado: (2026)

A physics and data co-driven surrogate modeling method for high-dimensional rare event simulation
por: Xian, Jianhua, et al.
Publicado: (2023)

Weighting methods for truncation by death in cluster-randomized trials
por: Isenberg, Dane, et al.
Publicado: (2024)

A Bayesian factor analysis model for non-randomised staggered designs
por: Schmidt, Constantin, et al.
Publicado: (2025)

Dose optimization design accounting for unknown patient heterogeneity in cancer clinical trials
por: Silva, Rebecca B., et al.
Publicado: (2025)

Assurance Methods for designing a clinical trial with a delayed treatment effect
por: Salsbury, James, et al.
Publicado: (2023)

Eliciting prior information from clinical trials via calibrated Bayes factor
por: Demartino, Roberto Macrì, et al.
Publicado: (2024)

Adaptive L-tests for high dimensional independence
por: Zhao, Ping, et al.
Publicado: (2026)

Using shrinkage methods to estimate treatment effects in overlapping subgroups in randomized clinical trials with a time-to-event endpoint
por: Wolbers, Marcel, et al.
Publicado: (2024)

Sensitivity analysis method in the presence of a missing not at random ordinal independent variable
por: Dioni, Abdoulaye, et al.
Publicado: (2025)

Doubly protected estimation for survival outcomes utilizing external controls for randomized clinical trials
por: Gao, Chenyin, et al.
Publicado: (2024)

Multilevel functional distributional models with application to continuous glucose monitoring in diabetes clinical trials
por: Matabuena, Marcos, et al.
Publicado: (2024)

One-sample survival tests in the presence of non-proportional hazards in oncology clinical trials
por: Szurewsky, Chloé, et al.
Publicado: (2025)